Fleming F, Bohn D, Edwards H, Cox P, Geary D, McCrindle B W, Williams W G
Pediatric Intensive Care Unit, Hospital for Sick Children, Toronto, Ontario, Canada.
J Thorac Cardiovasc Surg. 1995 Feb;109(2):322-31. doi: 10.1016/S0022-5223(95)70394-2.
The development of renal failure necessitating peritoneal dialysis after cardiac operations is associated with a reported mortality greater than 50%. Improved fluid removal and nutritional support have been reported with the use of continuous arteriovenous hemofiltration and continuous venovenous hemofiltration techniques. We have compared our experience with all three techniques in managing children who required renal replacement therapy after cardiac operations in terms of efficacy (fluid removal, calorie intake, and clearance of urea and creatinine), complications, and outcome. Over a 5-year period renal replacement therapy was initiated in 42 children, and in 34 of them it was successfully established for more than a 24-hour period: 17 were managed with peritoneal dialysis, 8 with continuous arteriovenous hemofiltration, and 9 with continuous venovenous hemofiltration. A net negative fluid balance was achieved in only 6 (35%) patients treated with peritoneal dialysis compared with 50% of those treated with continuous venovenous hemofiltration and 89% of those treated with continuous venovenous hemofiltration. In terms of nutritional support, calorie intake increased by 43% after peritoneal dialysis was started compared with 515% and 409% in the arteriovenous and venovenous hemofiltration groups, respectively, (p < 0.005). The serum urea levels fell by 36% (p = 0.02) and 39% (p = 0.005) compared with pre-therapy levels with arteriovenous and venovenous hemofiltration, respectively, and the creatinine content was reduced by 19% and 33% (p = 0.003). Neither parameter was reduced in the peritoneal dialysis group. We conclude that the use of hemofiltration as a renal replacement therapy after surgical correction of congenital heart disease offers significant advantages over the more traditional approach of peritoneal dialysis. In addition, we suggest that a more aggressive approach to the management of fluid overload and nutritional depletion with hemofiltration may result in a decrease in the very high mortality seen in renal failure after cardiac operations.
心脏手术后出现肾衰竭并需要进行腹膜透析的情况,据报道死亡率超过50%。据报道,采用连续动静脉血液滤过和连续静脉-静脉血液滤过技术可改善液体清除和营养支持。我们比较了在管理心脏手术后需要肾脏替代治疗的儿童时,我们在使用这三种技术方面的经验,包括疗效(液体清除、热量摄入以及尿素和肌酐清除率)、并发症和结局。在5年期间,42名儿童开始接受肾脏替代治疗,其中34名成功建立治疗超过24小时:17名接受腹膜透析治疗,8名接受连续动静脉血液滤过治疗,9名接受连续静脉-静脉血液滤过治疗。接受腹膜透析治疗的患者中只有6名(35%)实现了净负液体平衡,相比之下,接受连续静脉-静脉血液滤过治疗的患者中有50%实现了净负液体平衡,接受连续动静脉血液滤过治疗的患者中有89%实现了净负液体平衡。在营养支持方面,开始腹膜透析后热量摄入增加了43%,相比之下,动静脉血液滤过组和静脉-静脉血液滤过组分别增加了515%和409%(p<0.005)。与治疗前水平相比,动静脉血液滤过和静脉-静脉血液滤过治疗后血清尿素水平分别下降了36%(p=0.02)和39%(p=0.005),肌酐含量分别降低了19%和33%(p=0.003)。腹膜透析组这两个参数均未降低。我们得出结论,在先天性心脏病手术矫正后,使用血液滤过作为肾脏替代治疗比更传统的腹膜透析方法具有显著优势。此外,我们建议采用更积极的方法通过血液滤过来管理液体超负荷和营养消耗,这可能会降低心脏手术后肾衰竭中所见的极高死亡率。